Business Description
Cadrenal Therapeutics Inc
NAICS : 541713
SIC : 2833
ISIN : US1276361086
Description
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 559.67 | |||||
| Equity-to-Asset | 0.73 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 13.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.31 | |||||
| 9-Day RSI | 57.06 | |||||
| 14-Day RSI | 55.65 | |||||
| 6-1 Month Momentum % | -28.17 | |||||
| 12-1 Month Momentum % | -41.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.72 | |||||
| Quick Ratio | 3.72 | |||||
| Cash Ratio | 3.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -78.95 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -104.64 | |||||
| ROA % | -91.99 | |||||
| ROIC % | -1606.88 | |||||
| ROC (Joel Greenblatt) % | -26879.31 | |||||
| ROCE % | -104.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.97 | |||||
| Price-to-Tangible-Book | 1.97 | |||||
| EV-to-EBIT | -0.45 | |||||
| EV-to-Forward-EBIT | -0.29 | |||||
| EV-to-EBITDA | -0.45 | |||||
| EV-to-Forward-EBITDA | -0.29 | |||||
| EV-to-FCF | -0.6 | |||||
| Price-to-Net-Current-Asset-Value | 1.97 | |||||
| Price-to-Net-Cash | 2.2 | |||||
| Earnings Yield (Greenblatt) % | -222.22 | |||||
| FCF Yield % | -59.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CVKD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cadrenal Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5.55 | ||
| Beta | 0 | ||
| Volatility % | 184.18 | ||
| 14-Day RSI | 55.65 | ||
| 14-Day ATR ($) | 0.843353 | ||
| 20-Day SMA ($) | 6.744574 | ||
| 12-1 Month Momentum % | -41.23 | ||
| 52-Week Range ($) | 5.399999 - 32.549999 | ||
| Shares Outstanding (Mil) | 1.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cadrenal Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cadrenal Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cadrenal Therapeutics Inc Frequently Asked Questions
What is Cadrenal Therapeutics Inc(CVKD)'s stock price today?
The current price of CVKD is $7.36. The 52 week high of CVKD is $32.55 and 52 week low is $5.40.
When is next earnings date of Cadrenal Therapeutics Inc(CVKD)?
The next earnings date of Cadrenal Therapeutics Inc(CVKD) is .
Does Cadrenal Therapeutics Inc(CVKD) pay dividends? If so, how much?
Cadrenal Therapeutics Inc(CVKD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers